• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session

    8/9/22 1:26:48 PM ET
    $AEL
    $AIHS
    $AKAN
    $ALVR
    Life Insurance
    Finance
    Finance: Consumer Services
    Finance
    Get the next $AEL alert in real time by email

    Gainers

    • Verona Pharma plc (NASDAQ:VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
    • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) shares surged 49.3% to $1.3405. eFFECTOR Therapeutics appointed Douglas Warner, M.D., as chief medical officer.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) gained 47% to $1.0799 after the company announced its subsidiary REIT Ecological Technology has won the bid for the Longxi County Comprehensive Land Management and Logistics Zone EOD Project.
    • BBQ Holdings, Inc. (NASDAQ:BBQ) gained 45.6% to $17.06 after the company announced MTY Food Group entered into a definitive merger agreement to acquire all of the outstanding shares of the company for $17.25 per share.
    • Akanda Corp. (NASDAQ:AKAN) gained 45.6% to $1.3991. Akanda will supply Cansativa with premium indoor cannabis flower grown at its Sintra facility in Portugal.
    • Helbiz, Inc. (NASDAQ:HLBZ) rose 38.8% to $2.2350 after jumping 115% on Monday.
    • Tuesday Morning Corporation (NASDAQ:TUEM) rose 33.5% to $0.4811 after gaining around 68% on Monday.
    • ZK International Group Co., Ltd. (NASDAQ:ZKIN) jumped 31.2% to $1.64. ZK International won a $75 million bid in 'high quality drinking water household project.'
    • Mersana Therapeutics, Inc. (NASDAQ:MRSN) shares gained 30.9% to $6.87. Mersana Therapeutics announced a global collaboration that provides GSK plc an exclusive option to co-develop and commercialize XMT-2056.
    • Atara Biotherapeutics, Inc. (NASDAQ:ATRA) gained 24.5% to $4.52 after reporting a profit for the second quarter.
    • PubMatic, Inc. (NASDAQ:PUBM) jumped 22.8% to $21.81 after reporting strong quarterly results.
    • Nielsen Holdings plc (NYSE:NLSN) surged 21.3% to $27.56. Nielsen postponed court and special meetings of shareholders to permit finalization of preliminary agreement between consortium and The WindAcre Partnership LLC.
    • RumbleON, Inc. (NASDAQ:RMBL) gained 21.1% to $24.75 after the company reported better-than-expected Q2 results.
    • Edgio, Inc. (NASDAQ:EGIO) jumped 19.5% to $3.3596 after the company reported better-than-expected Q2 results.
    • Ambac Financial Group, Inc. (NYSE:AMBC) jumped 18% to $13.16 following upbeat Q2 results.
    • ShockWave Medical, Inc. (NASDAQ:SWAV) gained 17.2% to $259.96 after the company reported better-than-expected Q2 EPS and sales results and raised FY22 sales guidance above analyst estimates.
    • Tricida, Inc. (NASDAQ:TCDA) gained 17% to $12.64 following strong quarterly earnings.
    • Heron Therapeutics, Inc. (NASDAQ:HRTX) jumped 16.8% to $4.17 after the company posted upbeat quarterly sales and raised FY22 net product sales guidance.
    • Ontrak, Inc. (NASDAQ:OTRK) shares rose 16% to $0.7892. Ontrak recently reported closing of registered direct offering for aggregate gross proceeds of $4.0 million.
    • Horizon Global Corporation (NYSE:HZN) gained 14.3% to $1.60 following Q2 results.
    • Lemonade, Inc. (NYSE:LMND) shares rose 13.7% to $28.56 after the company reported better-than-expected Q2 results and issued sales guidance above estimates.
    • AlloVir, Inc. (NASDAQ:ALVR) gained 13.4% to $7.96. The company recently released quarterly results.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) jumped 13.3% to $0.1472. T2 Biosystems said it will explore potential to develop rapid molecular diagnostic test for monkeypox virus.
    • American Equity Investment Life Holding Company (NYSE:AEL) rose 12.1% to $40.62 after the company reported better-than-expected Q2 EPS and sales results.
    • BIMI International Medical Inc. (NASDAQ:BIMI) shares gained 11.6% to $0.6851 after Fnu Oudom reported a stake of 44% in the company in a 13D filing.
    • Qualys, Inc. (NASDAQ:QLYS) gained 10.6% to $141.05 after the company reported better-than-expected Q2 EPS and sales results and issued FY22 sales guidance above analyst estimates.
    • PowerSchool Holdings, Inc. (NYSE:PWSC) jumped 10.4% to $17.08 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 and FY22 sales guidance above analyst estimates.
    • Luminar Technologies, Inc. (NASDAQ:LAZR) gained 8.3% to $8.57 after the company reported better-than-expected Q2 sales results.
    • Comstock Resources, Inc. (NYSE:CRK) jumped 7.7% to $15.99.
    • GoodRx Holdings, Inc. (NASDAQ:GDRX) rose 7% to $8.30 after the company reported better-than-expected Q2 sales results.
    • Principal Financial Group, Inc. (NYSE:PFG) gained 7% to $73.60 after the company reported better-than-expected Q2 adjusted EPS results. Additionally, Morgan Stanley raised its price target from $65 to $68.
    • Enovix Corporation (NASDAQ:ENVX) rose 6.2% to $14.56 after declining around 5% on Monday. JP Morgan recently initiated coverage on Enovix with an Overweight rating and announced a price target of $20.
    • Peraso Inc. (NASDAQ:PRSO) rose 6.1% to $2.61. Peraso recently received customer orders totaling $6.4 million for mmWave Fixed Wireless Access market.
    • News Corporation (NASDAQ:NWSA) gained 5.5% to $18.33 after the company reported Q4 EPS results up year over year and better-than-expected sales results.
    • Desktop Metal, Inc. (NYSE:DM) shares rose 5% to $2.7175 after posting better-than-expected Q2 sales.


    Losers

    • Magic Empire Global Limited (NASDAQ:MEGL) fell 82.4% to $20.55 on volatility following the company's IPO on Friday.
    • Quanterix Corporation (NASDAQ:QTRX) shares dipped 60.4% to $6.53 after the company announced Q2 results and provided an update on clinical development programs.
    • CorMedix Inc. (NASDAQ:CRMD) fell 56.4% to $3.28 after the company announced it received a second Complete Response Letter from the FDA stating that the DefenCath NDA cannot be approved until certain deficiencies are resolved to the satisfaction of the FDA.
    • Aytu BioPharma, Inc. (NASDAQ:AYTU) shares fell 50.6% to $0.2865 after the company announced the launch of public offering.
    • Vertex Energy, Inc. (NASDAQ:VTNR) dipped 47.3% to $7.37 after the company reported worse-than-expected Q2 EPS.
    • AMTD Digital Inc. (NYSE:HKD) dropped 40.7% to $240.00 on possible profit taking after the stock surged over the last few trading days.
    • Medicenna Therapeutics Corp. (NASDAQ:MDNA) fell 40.5% to $1.06 after the company announced the launch of a marketed underwritten public offering of 13,333,334 units priced at $1.50 per unit.
    • SKYX Platforms Corp. (NASDAQ:SKYX) dropped 38.6% to $3.7699. SKYX achieved historic U.S. standardization approval vote – a major milestone towards mandatory status for safety of consumers and professionals.
    • Avaya Holdings Corp. (NASDAQ:AVYA) fell 37.3% to $0.7031 after the company issued Q3 EPS and sales guidance below analyst estimates.
    • Endo International plc (NASDAQ:ENDP) declined 35.5% to $0.4310 after the company reported a 20% year-over-year drop in Q2 revenues and said it remains in negotiations with creditors. The company expects negotiations to result in a pre-arranged filing under Chapter 11 of the U.S. Bankruptcy Code
    • Senmiao Technology Limited (NASDAQ:AIHS) dipped 35.3% to $1.23 after the company reported ride-hailing platform operating metrics for July.
    • Vroom, Inc. (NASDAQ:VRM) dropped 34% to $1.6223 after the company reported worse-than-expected Q2 sales.
    • Turtle Beach Corporation (NASDAQ:HEAR) shares fell 33.8% to $9.26 after reporting downbeat second quarter financial results and announced an update to a strategic review.
    • DermTech, Inc. (NASDAQ:DMTK) declined 31.4% to $5.78 after the company reported worse-than-expected Q2 sales results.
    • Novavax, Inc. (NASDAQ:NVAX) fell 29.7% to $40.25 after the company reported second-quarter revenue decline of 37.6% year-over-year to $185.9 million. The company also lowered its sales forecast for the year.
    • Oportun Financial Corporation (NASDAQ:OPRT) dropped 29.6% to $7.58 following Q2 results.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) dipped 27% to $1.2999. Iveda Solutions announced a $5 million private placement.
    • Assure Holdings Corp. (NASDAQ:IONM) fell 25.8% to $1.77.
    • Root, Inc. (NASDAQ:ROOT) fell 25.7% to $1.0150 after the company reported Q2 results and announced a 1-for-18 reverse stock split.
    • Bonso Electronics International Inc. (NASDAQ:BNSO) fell 25.4% to $5.88 after gaining 65% on Monday.
    • Superior Group of Companies, Inc. (NASDAQ:SGC) declined 25.2% to $13.96 following downbeat quarterly earnings.
    • Shift Technologies, Inc. (NASDAQ:SFT) dipped 25.2% to $1.1450.
    • Eargo, Inc. (NASDAQ:EAR) fell 24.8% to $1.03 after the company posted a wider Q2 loss.
    • Allbirds, Inc. (NASDAQ:BIRD) fell 24.2% to $4.2991 after the company issued Q3 and FY22 sales guidance below estimates.
    • Westport Fuel Systems Inc. (NASDAQ:WPRT) declined 23.5% to $1.1850 after reporting a Q2 loss.
    • TaskUs, Inc. (NASDAQ:TASK) dropped 23.3% to $17.97 after the company issued FY22 sales guidance below estimates.
    • CarGurus, Inc. (NASDAQ:CARG) fell 21.9% to $20.09 after the company issued weak forecast for the third quarter.
    • Standard BioTools Inc. (NYSE:LAB) declined 20.8% to $1.6150 following Q2 results.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) dropped 20.7% to $0.6330.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 20.7% to $ 9.05. Baird downgraded Bed Bath & Beyond from Neutral to Underperform and announced a $4 price target.
    • Clover Health Investments, Corp. (NASDAQ:CLOV) fell 17.7% to $2.80 after the company reported financial results and reaffirmed full-year guidance.
    • Aterian, Inc. (NASDAQ:ATER) fell 15.4% to $2.5201 as the company reported second-quarter financial results.
    • Wayfair Inc. (NYSE:W) dropped 14.6% to $61.26.
    • 3D Systems Corporation (NYSE:DDD) shares fell 14.5% to $11.30 after the company reported a loss for its second quarter and lowered its FY22 sales guidance.
    • Trex Company, Inc. (NYSE:TREX) fell 14.1% to $54.85 following Q2 results.
    • Signet Jewelers Limited (NYSE:SIG) declined 13.1% to $58.79 after the company cut FY23 sales guidance below analyst estimates.
    • Freshpet, Inc. (NASDAQ:FRPT) fell 12.8% to $49.13 after the company reported worse-than-expected Q2 EPS and sales results.
    • Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) dipped 12.2% to $11.88 after the company reported worse-than-expected Q2 results and issued Q3 guidance below estimates.
    • Helios Technologies, Inc. (NASDAQ:HLIO) fell 11.8% to $61.96 after the company reported Q2 earnings results.
    • ICU Medical, Inc. (NASDAQ:ICUI) dipped 11.4% to $166.66 after the company reported worse-than-expected Q2 EPS and sales results.
    • Doximity, Inc. (NYSE:DOCS) fell 11.1% to $36.09. Doximity recently lowered FY23 sales guidance.
    • Cepton, Inc. (NASDAQ:CPTN) fell 10.4% to $1.64 after the company posted a loss for its second quarter and issued weak sales forecast for FY22.
    • Upstart Holdings, Inc (NASDAQ:UPST) fell 10.3% to $28.95 after the company reported Q2 results and issued Q3 sales guidance below estimates.
    • Coinbase Global, Inc. (NASDAQ:COIN) fell 9.8% to $88.54.
    • Synaptics Incorporated (NASDAQ:SYNA) dropped 9.8% to $130.86.
    • bluebird bio, Inc. (NASDAQ:BLUE) fell 9.2% to $5.76 after jumping 13% on Monday.
    • 23andMe Holding Co (NASDAQ:ME) fell 8.7% to $3.6350 after the company reported worse-than-expected Q2 EPS results.
    • TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) fell 8.5% to $1.1799. TOMI Environmental Solutions shares jumped over 29% on Monday after the company highlighted its SteraMist as a disinfectant against the Monkeypox virus.
    • Ralph Lauren Corporation (NYSE:RL) fell 6.5% to $94.64 following Q1 results.
    • Tesla, Inc. (NASDAQ:TSLA) fell 3.2% to $843.30.
    Get the next $AEL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEL
    $AIHS
    $AKAN
    $ALVR

    CompanyDatePrice TargetRatingAnalyst
    Wayfair Inc.
    $W
    2/20/2026$114.00 → $105.00Overweight
    Analyst
    Upstart Holdings Inc.
    $UPST
    2/17/2026$30.00Sell → Neutral
    Compass Point
    Upstart Holdings Inc.
    $UPST
    2/13/2026$20.00Mkt Perform → Mkt Underperform
    Citizens
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Upstart Holdings Inc.
    $UPST
    2/13/2026$35.00Sell → Neutral
    Goldman
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $AEL
    $AIHS
    $AKAN
    $ALVR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AEL
    $AIHS
    $AKAN
    $ALVR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Talluri Rajendra K covered exercise/tax liability with 17,650 shares, decreasing direct ownership by 0.79% to 2,202,787 units (SEC Form 4)

    4 - Enovix Corp (0001828318) (Issuer)

    2/20/26 6:42:04 PM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Vice President of Land Sanders Larae Lynn covered exercise/tax liability with 1,940 shares, decreasing direct ownership by 0.75% to 257,919 units (SEC Form 4)

    4 - COMSTOCK RESOURCES INC (0000023194) (Issuer)

    2/20/26 6:36:34 PM ET
    $CRK
    Oil & Gas Production
    Energy

    VP of Accounting Presley Daniel K covered exercise/tax liability with 1,897 shares, decreasing direct ownership by 0.70% to 268,257 units (SEC Form 4)

    4 - COMSTOCK RESOURCES INC (0000023194) (Issuer)

    2/20/26 6:35:19 PM ET
    $CRK
    Oil & Gas Production
    Energy

    $AEL
    $AIHS
    $AKAN
    $ALVR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Casdin Partners Master Fund, L.P. bought $502,570 worth of shares (350,000 units at $1.44) (SEC Form 4)

    4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)

    12/4/25 8:59:44 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Casdin Partners Master Fund, L.P. bought $10,053,280 worth of shares (7,700,000 units at $1.31) (SEC Form 4)

    4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)

    11/26/25 4:58:37 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AEL
    $AIHS
    $AKAN
    $ALVR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst reiterated coverage on Wayfair with a new price target

    Analyst reiterated coverage of Wayfair with a rating of Overweight and set a new price target of $105.00 from $114.00 previously

    2/20/26 10:42:01 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    Upstart upgraded by Compass Point with a new price target

    Compass Point upgraded Upstart from Sell to Neutral and set a new price target of $30.00

    2/17/26 8:05:30 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Upstart downgraded by Citizens with a new price target

    Citizens downgraded Upstart from Mkt Perform to Mkt Underperform and set a new price target of $20.00

    2/13/26 8:31:11 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    $AEL
    $AIHS
    $AKAN
    $ALVR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.423 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion

    Bitmine has 3,040,483 staked ETH, representing $6.0 billion at $1,958 per ETH; MAVAN staking solution on track to launch Q1 2026Bitmine now owns 3.66% of the ETH token supply, over 73% of the way to the 'Alchemy of 5%' in just 7 monthsBitmine recently closed on initial $200 million investment into Beast IndustriesBitmine Crypto + Total Cash Holdings + "Moonshots" total $9.6 billion, including 4.423 million ETH tokens, total cash of $691 million, and other crypto holdingsBitmine leads crypto treasury peers by both the velocity of raising crypto NAV per share and by the high trading liquidity of BMNR stockBitmine is the 165th most traded stock in the US, trading $0.7 billion per day (5-day avg

    2/23/26 8:30:00 AM ET
    $BMNR
    $COIN
    $MSTR
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    ICU Medical to Participate in Upcoming Investor Conferences

    SAN CLEMENTE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Raymond James 47th Annual Institutional Investors Conference on March 2, 2026 Company management will present at the Raymond James 47th Annual Institutional Investors Conference in Orlando, FL on Monday, March 2, 2026. The presentation will begin at 11:15 a.m. PT (2:15 p.m. ET). KeyBanc Healthcare Forum on March 18, 2026 Company management will participate in a fireside chat at the KeyBanc Healthcare Forum, held virtually on Wednesday, March 18,

    2/23/26 8:30:00 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    TGE's Film "Scare Out" Exceeds US$120 Million at the Box Office in just 7 Days

    PARIS, NEW YORK and LONDON, Feb. 23, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE:AMTD, SGX: HKB)), AMTD Digital Inc. (NYSE:HKD) and The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that "Scare Out" (the "Movie"), the first ever national‑security film co‑produced by TGE, captured a significant share of the box office during the Chinese New Year window. Featuring an all‑star cast including Jackson Yee, Yilong Zhu, Jia Song, Jiayin Lei, Mi Yang, Yi Zhang, Cecilia Liu, and Yaowen Liu, the Movie achieved box office inflows of over US$120 million within just its first seven days of release.

    2/23/26 8:20:00 AM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    $AEL
    $AIHS
    $AKAN
    $ALVR
    SEC Filings

    View All

    Atara Biotherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events

    8-K - Atara Biotherapeutics, Inc. (0001604464) (Filer)

    2/23/26 8:29:11 AM ET
    $ATRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    News Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - NEWS CORP (0001564708) (Filer)

    2/23/26 8:04:37 AM ET
    $NWSA
    Newspapers/Magazines
    Consumer Discretionary

    Freshpet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Freshpet, Inc. (0001611647) (Filer)

    2/23/26 6:31:22 AM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    $AEL
    $AIHS
    $AKAN
    $ALVR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by RumbleOn Inc.

    SC 13D/A - RumbleOn, Inc. (0001596961) (Subject)

    12/10/24 9:00:06 PM ET
    $RMBL
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:32:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:31:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    $AEL
    $AIHS
    $AKAN
    $ALVR
    Financials

    Live finance-specific insights

    View All

    Freshpet, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    Full Year 2025 Net Sales Growth of 13% and Achieves Positive Free Cash Flow Provides Full Year 2026 Outlook BEDMINSTER, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Freshpet, Inc. ("Freshpet" or the "Company") (NASDAQ:FRPT) today reported financial results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Compared to Prior Year Period Net sales of $285.2 million, an increase of 8.6%.Gross margin of 43.3%, compared to the prior year period of 42.5%.Adjusted Gross Margin of 48.4%, compared to the prior year period of 48.1%.1Net income of $33.8 million, compared to the prior year period net income of $18.1 million.Adjusted EBITDA of $61.2 mi

    2/23/26 6:30:00 AM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

    Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Monday, March 2, 2026, at 4:30 p.m. E.T., to discuss its fourth quarter and full year 2025 financial results. Quanterix will issue a press release regarding its fourth quarter and full year 2025 financial results prior to the conference call on Monday, March 2, 2026, after the market closes. The press release will be posted on the Quanterix website at http://www.quanterix.com/. To listen to the live conference call, investors can dial (800) 715-9871 or (646) 307-1963 and enter conference ID 79

    2/20/26 8:33:00 AM ET
    $QTRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    CarGurus Announces Fourth Quarter and Full-Year 2025 Results

    Full-year 2025 revenue from continuing operations grew 14% YoY for the second consecutive year Full-year 2025 GAAP Net Income from continuing operations of $196.7 million, up 53% YoY; Non-GAAP Adjusted EBITDA from continuing operations of $319.0 million, up 25% YoY Repurchased approximately $350 million worth of shares in 2025, and announces new $250.0 million share repurchase program for 2026 BOSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- CarGurus, Inc. (NASDAQ:CARG), the No. 1 visited automotive shopping site in the U.S.1, today announced financial results for the fourth quarter and year ended December 31, 2025. "2025 was a pivotal year for CarGurus as we delivered strong financial perfor

    2/19/26 4:05:00 PM ET
    $CARG
    EDP Services
    Technology

    $AEL
    $AIHS
    $AKAN
    $ALVR
    Leadership Updates

    Live Leadership Updates

    View All

    Superior Group of Companies to Announce Fourth Quarter and Full Year 2025 Results

    ST. PETERSBURG, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ:SGC) (the "Company") today announced that it will release the results of its operations for the fourth quarter and full year 2025 after the market close on Tuesday, March 3, 2026. Michael Benstock, Chairman and Chief Executive Officer, and Mike Koempel, President and Chief Financial Officer, will host a teleconference at 5:00 pm Eastern Time that day to discuss the Company's results. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/presentations. Interested individuals may also join the t

    2/17/26 4:22:00 PM ET
    $SGC
    Apparel
    Consumer Discretionary

    Norwegian Cruise Line Holdings Appoints John W. Chidsey as President and Chief Executive Officer

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of Directors has appointed John W. Chidsey, a director of NCLH, as President and Chief Executive Officer, effective immediately. Mr. Chidsey succeeds Harry Sommer, who is stepping down as President and Chief Executive Officer and as a Director of NCLH. Mr. Chidsey has a proven track record of leading large global consumer-facing companies through strategic and operational transformation, with experience across franchised operating models, as well as yield-dri

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    PubMatic Appoints Marketing Veteran John Petralia as Chief Marketing Officer to Accelerate AI-Driven Growth

    Appointment strengthens commercial leadership as PubMatic scales AI-powered advertising across CTV, mobile and omnichannel media. PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, today announced the appointment of John Petralia as Chief Marketing Officer. Petralia will lead PubMatic's global marketing organization as the company scales AI-powered advertising technology across premium connected TV (CTV), mobile app, and omnichannel media. His appointment comes as publishers and brands move from AI experimentation to live, measurable execution – placing new emphasis on clarity, measurable performance, and trusted scalability. His

    2/12/26 8:00:00 AM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    $AEL
    $AIHS
    $AKAN
    $ALVR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care